🇺🇸 FDA
Patent

US 11072794

Compositions and their uses directed to huntingtin

granted A61PA61P25/00A61P25/14

Quick answer

US patent 11072794 (Compositions and their uses directed to huntingtin) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P25/00, A61P25/14, A61P25/28